Cargando…

Salidroside attenuates atrial fibrosis and atrial fibrillation vulnerability induced by angiotensin-II through inhibition of LOXL2-TGF-β1-Smad2/3 pathway

AIMS AND OBJECTIVES: Salidroside (SAL), an active component isolated from the Chinese plant Rose Rhodiola, has anti-inflammatory, antioxidant, anti-cancer, neuroprotective, and renal protective properties. Atrial fibrosis developed due to angiotensin II (Ang II) plays a crucial function in developin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hai, Zhen, Wu, Yingbiao, Ning, Zhongping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618763/ https://www.ncbi.nlm.nih.gov/pubmed/37920527 http://dx.doi.org/10.1016/j.heliyon.2023.e21220

Ejemplares similares

Irisin attenuates angiotensin II-induced atrial fibrillation and atrial fibrosis via LOXL2 and TGFβ1/Smad2/3 signaling pathways
por: Wu, Yingbiao, et al.
Publicado: (2023)

PU.1 inhibition attenuates atrial fibrosis and atrial fibrillation vulnerability induced by angiotensin‐II by reducing TGF‐β1/Smads pathway activation
por: Hu, Juan, et al.
Publicado: (2021)

LOXL2 silencing suppresses angiotensin II-induced cardiac hypertrophy through the EMT process and TGF-β1/Smad3/NF-κB pathway
por: Luo, Jun, et al.
Publicado: (2022)

Apelin Inhibits Angiotensin II-Induced Atrial Fibrosis and Atrial Fibrillation via TGF-β1/Smad2/α-SMA Pathway
por: Lv, Wenkui, et al.
Publicado: (2020)

Meta-Analysis of Catheter Ablation versus Medical Therapy for Heart Failure Complicated with Atrial Fibrillation
por: Zhu, Xi, et al.
Publicado: (2021)

Relationship between serum angiopoietin-like 4 levels and recurrence of atrial fibrillation
por: Ning, Zhongping, et al.
Publicado: (2021)

ANGPTL4 Attenuates Ang II-Induced Atrial Fibrillation and Fibrosis in Mice via PPAR Pathway
por: Zhu, Xi, et al.
Publicado: (2021)

CTRP9 Ameliorates Atrial Inflammation, Fibrosis, and Vulnerability to Atrial Fibrillation in Post‐Myocardial Infarction Rats
por: Liu, Mingxin, et al.
Publicado: (2019)

LncRNA PVT1 regulates atrial fibrosis via miR-128-3p-SP1-TGF-β1-Smad axis in atrial fibrillation
por: Cao, Feng, et al.
Publicado: (2019)

Blockade of SK4 channels suppresses atrial fibrillation by attenuating atrial fibrosis in canines with prolonged atrial pacing
por: Wang, Youcheng, et al.
Publicado: (2022)

Left atrial effective conducting size predicts atrial fibrillation vulnerability in persistent but not paroxysmal atrial fibrillation
por: Williams, Steven E., et al.
Publicado: (2019)

Atrial fibrosis progression in patients with Atrial Fibrillation
por: White, Robert B, et al.
Publicado: (2016)

Atrial Fibrosis, Ischaemic Stroke and Atrial Fibrillation
por: Mahnkopf, Christian, et al.
Publicado: (2021)

Atrial fibrosis underlying atrial fibrillation (Review)
por: Li, Chang Yi, et al.
Publicado: (2021)

Linggui Qihua Decoction Inhibits Atrial Fibrosis by Regulating TGF-β1/Smad2/3 Signal Pathway
por: Xiong, Shuang, et al.
Publicado: (2023)

Doxycycline Improves Fibrosis-Induced Abnormalities in Atrial Conduction and Vulnerability to Atrial Fibrillation in Chronic Intermittent Hypoxia Rats
por: Ma, Zuowang, et al.
Publicado: (2020)

Cadherin-11 Deficiency Attenuates Ang-II-Induced Atrial Fibrosis and Susceptibility to Atrial Fibrillation
por: Cao, Wei, et al.
Publicado: (2021)

Linking LOXL2 to Cardiac Interstitial Fibrosis
por: Erasmus, Melisse, et al.
Publicado: (2020)

Role of serum TGF-β1 level in atrial fibrosis and outcome after catheter ablation for paroxysmal atrial fibrillation
por: Tian, Ye, et al.
Publicado: (2017)

Suppression of ADAM8 attenuates angiotensin II-induced cardiac fibrosis and endothelial-mesenchymal transition via inhibiting TGF-β1/Smad2/Smad3 pathways
por: Yao, Lixia, et al.
Publicado: (2021)

Bone Morphogenetic Protein-7 Antagonizes Myocardial Fibrosis Induced by Atrial Fibrillation by Restraining Transforming Growth Factor-β (TGF-β)/Smads Signaling
por: Chen, Xinjun, et al.
Publicado: (2016)

LOXL4, but not LOXL2, is the critical determinant of pathological collagen cross-linking and fibrosis in the lung
por: Ma, Hsiao-Yen, et al.
Publicado: (2023)

Effect of angiotensin receptor-neprilysin inhibitor on atrial electrical instability in atrial fibrillation
por: Zhu, Tianyu, et al.
Publicado: (2022)

Regional and temporal progression of atrial remodeling in angiotensin II mediated atrial fibrillation
por: Jansen, Hailey J., et al.
Publicado: (2022)

Intermedin 1-53 Ameliorates Atrial Fibrosis and Reduces Inducibility of Atrial Fibrillation via TGF-β1/pSmad3 and Nox4 Pathway in a Rat Model of Heart Failure
por: Ma, Shenzhou, et al.
Publicado: (2023)

Human Epicardial Adipose Tissue cTGF Expression is an Independent Risk Factor for Atrial Fibrillation and Highly Associated with Atrial Fibrosis
por: Wang, Qing, et al.
Publicado: (2018)

Atrial fibrosis: an obligatory component of arrhythmia mechanisms in atrial fibrillation?
por: Platonov, Pyotr G
Publicado: (2017)

Atrial fibrosis: an obligatory component of arrhythmia mechanisms in atrial fibrillation?
por: Platonov, Pyotr G
Publicado: (2017)

Angiotensin‐Converting Enzyme‐2 Overexpression Improves Atrial Remodeling and Function in a Canine Model of Atrial Fibrillation
por: Zhou, Tingquan, et al.
Publicado: (2015)

Modulation of miR-10a-mediated TGF-β1/Smads signaling affects atrial fibrillation-induced cardiac fibrosis and cardiac fibroblast proliferation
por: Li, Peng-Fei, et al.
Publicado: (2019)

Cardiac-specific knockdown of Bhlhe40 attenuates angiotensin II (Ang II)-Induced atrial fibrillation in mice
por: Ren, Kai-Wen, et al.
Publicado: (2022)

Azithromycin Attenuates Bleomycin-Induced Pulmonary Fibrosis Partly by Inhibiting the Expression of LOX and LOXL-2
por: Tong, Xiang, et al.
Publicado: (2021)

Angiotensin II-mediated up-regulation of connective tissue growth factor promotes atrial tissue fibrosis in the canine atrial fibrillation model
por: Kiryu, Michiro, et al.
Publicado: (2012)

Profiling of miR-205/P4HA3 Following Angiotensin II-Induced Atrial Fibrosis: Implications for Atrial Fibrillation
por: Xiao, Zezhou, et al.
Publicado: (2021)

Dronedarone attenuates the duration of atrial fibrillation in a dog model of sustained atrial fibrillation
por: Saengklub, Nakkawee, et al.
Publicado: (2017)

Atrial myocyte-derived exosomal microRNA contributes to atrial fibrosis in atrial fibrillation
por: Hao, Hongting, et al.
Publicado: (2022)

Atrial Fibrosis by cardiac MRI is a correlate for atrial stiffness in patients with atrial fibrillation
por: Lamy, Jérôme, et al.
Publicado: (2023)

The Dose-Dependent Effects of Spironolactone on TGF-β1 Expression and the Vulnerability to Atrial Fibrillation in Spontaneously Hypertensive Rats
por: Tang, Mirong, et al.
Publicado: (2021)

miR-15a-5p regulates myocardial fibrosis in atrial fibrillation by targeting Smad7
por: He, Dan, et al.
Publicado: (2021)

Retraction: Modulation of miRNA-10a-mediated TGF-β1/Smads signaling affects atrial fibrillation-induced cardiac fibrosis and cardiac fibroblast proliferation
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fgvj716jpbstp9454up9ohpmld